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Abstract 
Neonatal maternal deprivation (NMD) increases gut paracellular permeability (GPP) through 
mast cells and nerve growth factor (NGF), and modifies corticotrophin-releasing factor (CRF) 
and corticosterone levels. CRF, corticosterone and mast cells are involved in stress-induced 
mucosal barrier impairment. Consequently, this study aimed to specify whether 
corticosteronaemia and colonic expression of both preproCRF and CRF are modified by 
NMD, and to determine if altered expression may participate in the elevated GPP in 
connection with NGF and mast cells. Male Wistar rat pups were either separated from 
postnatal days 2–14, or left undisturbed with their dam. At 12 weeks of age, adult rats were 
treated with mifepristone (an antagonist of corticoid receptors), a-helical CRF(9-41) (a non-
specific CRF receptor antagonist), or SSR-125543 (CRF-R1 receptor antagonist).We also 
determined corticosteronaemia and both colonic preproCRF and CRF expression. Then, 
control rats were treated by CRF, doxantrazole (mast cell stabilizer), BRX-537A (a mast cell 
activator) and anti-NGF antibody. NMD did not modify colonic CRF level but increased 
colonic preproCRF expression and corticosteronaemia. Peripheral CRF, via CRF-R1 receptor, 
but not corticosterone, was involved in the elevated GPP observed in these rats, through a 
mast-cell-mediated mechanism, since the increase of GPP induced by exogenous CRF was 
abolished by doxantrazole. Anti-NGF antibody treatment also reduced the elevated GPP 
induced by CRF or BRX-537A. CRF acts through CRF-R1 receptors to stimulate NGF 
release from mast cells, which participates in the elevated GPP observed inNMD adult rats. 
This suggests that early traumatic experience induced neuro-endocrine dysfunction, involved 
in alterations of gut mucosal barrier. 
 
There is evidence that early life trauma and ongoing psychological stress can affect the 
clinical course of intestinal disorders(Levenstein et al. 2000; Mayer et al. 2001) and also 
reactivate (Collins, 2001) or enhance (Gue et al. 1997) inflammation in experimental colitis. 
Thus, childhood adverse events, considered as potent stressors are often associated in humans 
with gastrointestinal diseases such as Crohn’s disease (Ringel & Drossman, 2001) or irritable 
bowel syndrome (IBS) (Hislop, 1979; Lowman et al. 1987). In animal models, neonatal 
maternal deprivation (NMD) has been found to predispose to colonic barrier dysfunction 
(Barreau et al. 2004b, 2006) and to enhance mucosal response to a mild stress (Soderholm et 
al. 2002). 
However, the mechanisms underlying the effects of neonatal stress on the induction or 
exacerbation of colonic mucosal barrier dysfunction remain largely unknown. In adult rats, 
acute or chronic stress induces short-term intestinal alterations, through mechanisms 
involving corticotrophin-releasing factor (CRF) (Santos et al. 1999; Saunders et al. 2002), 
glucocorticoids (Meddings&Swain, 2000) and mast cells (Santos et al. 2001). In agreement 
with the hypothesis of CRF involvement in stress-induced immediate gut permeability 
alterations, it has been reported that systemic administration ofCRFincreases gut permeability 
(Santos et al. 1999). Biological actions ofCRF are exerted by interacting with two distinct 
CRF receptors subtypes, CRF-R1 and CRF-R2, both being expressed in the gastrointestinal 
tract (Chatzaki et al. 2004). These receptors belong to the family of G protein-coupled 
receptors signalling through cAMP synthesis (Hauger et al. 2003). Although CRF is largely 
produced in the hypothalamus, a peripheral synthesis has been detected in colonic mucosal 
cells in the neighbourhood of the base of the crypts (Kawahito et al. 1994), and its local 
release may play a role in the modulation of the intestinal immune system and/or other 
gastrointestinal functions, either basally or under stressful conditions. However, the central or 
peripheral origin of CRF-mediated effects of stress on the mucosal barrier is still under 
debate. 
Among immune cells, mast cells play a critical role in the regulation of epithelial transport 
both in human (Crowe et al. 1997; Santos et al. 1998) and rodent intestine (Perdue et al. 1991; 
Berin et al. 1998), and it is widely accepted that nerve–mast cell interactions are involved in 
intestinal epithelial dysfunction (Argenzio, 1997; Coelho et al. 2000). Nerves and mast cells 
participate in the development of stress-induced increase of colonic paracellular permeability 
(Castagliuolo et al. 1998; Santos et al. 1999). Indeed, a mast cell stabilizer, doxantrazole, 
abolishes acute stress-induced ion secretion and permeability increase in the rat colon, and 
these effects are not observed in mast cell-deficient mice (Castagliuolo et al. 1998). However, 
it remains to be confirmed that mast cells are involved in the increased gut paracellular 
permeability (GPP) induced by CRF. 
Concerning the effects of neonatal stress on mast cells, some investigations have reported that 
NMD increases the number of colonic mucosal mast cells (Barreau et al. 2004b), and that 
daily handling of new-born rats enhances the number of mast cells within thalamus nuclei in 
adult rats (Lafreniere et al. 2001). Moreover, we have previously shown that mast cell 
stabiliser doxantrazole and anti-NGF (nerve growth factor) antibody (Ab) treatment in adult 
rats abolished the increase in GPP induced by NMD (Barreau et al. 2004a). Thus, both mast 
cells and NGF play together a pivotal role in the elevated GPP observed inNMDadult 
rats.However, although NGF may stimulate mast cell proliferation and degranulation, the 
pathway involving NGF and mast cells in the regulation of GPP is unknown. Neonatal stress 
also affects the hypothalamic-pituitary-adrenal (HPA) axis, modifying the adrenocortical 
response tonovelty in adult rats (Biagini et al. 1998). NMD increases supraspinal (brain) CRF 
expression (Husum & Mathe, 2002; Vazquez et al. 2003) associated with an altered 
expression of glucocorticoid receptors (Ogawa et al. 1994) in the central nervous system. 
Takentogether, these data suggest that even thoughNGF is involved, during the neonatal 
period, in the genesis of long-term effect of NMD, corticosterone, CRF, mast cells and NGF 
also play a pivotal role in the gut barrier alterations induced by NMD in adult rats. 
Consequently this study aimed (1) to assess in adult rats whether corticosterone and CRF are 
involved in the permanent alterations of GPP induced byNMD;(2) to determine the type of 
CRF receptor involved and; (3) to investigate whether CRF and mast cells are involved in 
cascade with NGF. 
 
Methods 
Animals 
Primiparous pregnant femaleWistar ratswere individually housed in standard polypropylene 
cages containing 2.5 cm of wood chip bedding material. They were kept at a constant 
temperature (23±1°C) and maintained on a 12 : 12 h light : dark cycle (lights on at 7 am). 
Food (UAR pellets,Epinay,France)andwaterwere available ad libitum. Mothers and their pups, 
and then the young rats after weaning on day 22, were kept in the same conditions. 
Nenonatal maternal deprivation 
NMD was performed according to a previously validated method (Rosztoczy et al. 2003; 
Barreau et al. 2004b). Briefly, the litters were culled to 10 pups after delivery (day 1). NMD 
was performed daily for three consecutive hours (from 0900 to 1200 h), during which pups 
were removed from the home cage and kept in temperature-controlled cages at 28±1° C, 
where bedding was changed every day. This procedure was applied between postnatal days 2 
and 14. Control pups were left with their dam. From days 15–22, all control and maternally 
deprived pups were maintained with their dam. Weaning was performed on day 22, siblings 
were sex-matched, and males were selected. 
Gut paracellular permeability Assessment of GPP was performed using 51Cr-
ethylenediaminetetraacetic acetic (EDTA) as a selective marker of paracellular permeation of 
tight junctions. Thus, 0.7 µCi of 51Cr-EDTA (Perkin Elmer Life Science, Paris, France) was 
diluted in 500 µl water and administered by oral route. Rats were then placed in metabolic 
cages, and faeces and urine were separately collected during 24 h. The radioactivity found in 
urine was measured by a gamma-counter (Cobra II; Packard, Meridien, CT, USA). 
Permeability to 51Cr-EDTA was expressed as a percentage of the total administered 
radioactivity. 
 
PreproCRF immunohistochemistry 
Under anaesthesia (i.p. administration of 0.6 mg kg-1 acepromazine (Vetoquinol, Lure, 
France) and 120 mg kg-1 ketamine (Rhone-M´erieux, Lyon, France)), rats were 
exsanguinated by beheading, and a 2 cm-long portion of the colon was excised and washed in 
sterile saline. The collected fragments were fixed in Duboscq-Brazil solution for 24 h, 
dehydrated in ethanol solution, embedded in paraffin blocks, and cut into 5 µm sections. 
Paraffin sections were rehydrated and submerged in antigen retrieval solution (citrate buffer, 
10mm, pH6, 95°C, 3 min). After inhibition of endogenous peroxidases with 0.6% H2O2 in 
100% methanol for 30 min, and incubation in blocking solution (phosphate-buffered saline 
containing 1% bovine serum albumin and 2% normal donkey serum), sections were incubated 
with goat anti-preproCRF antibody (Santa Cruz, Le Perray en Yvelines, France) (1/100; 
overnight,+4°C) followed by a biotinylated donkey anti-goat IgG immune serum (Interchim, 
Montluc¸on, France) 1/1000; 30 min, RT. Slides were subsequently incubated with ABC 
complexes coupled to peroxidase (Abcys, Paris, France). 3-3’diaminobenzidine (ICN 
Pharmaceuticals, Costa Mesa, CA, USA) was used as chromogen. Immunoreactivity was 
graded from 0 to 3 indicating the degree of preproCRF expression (0, none; 1, weak; 2, 
intermediate; 3, strong). Grading was done in a blind fashion. 
Corticosterone assay 
Plasma sampleswere stored at-20°C until assayed. Plasma corticosterone concentrations were 
determined using an adapted high-performance liquid chromatography (HPLC) after a 
solid/liquid extraction on C8 cartridge and in the presence of internal standard (flumethasone 
2.5 µgml-1). An Inertsil ODS 33 µm (150×4.0 mm) column was eluted byH2O/methanol 
(50/50; v/v) mixing, and a 0.5 ml min-1 rate of flow was used to separate cortisol and 
corticosterone. The corticosterone detection was performed at 254 nm and the quantification 
limit of the method was 25 ng ml-1. 
 
Quantification of NGF release under CRF stimulation 
Under anaesthesia (i.p. administration of 0.6 mg kg-1 acepromazine (Vetoquinol, Lure, 
France) and 120 mg kg-1 ketamine (Rhone-M´erieux, Lyon, France)), rats were 
exsanguinated by beheading and four segments (0.5 cm) of distal colonwere immediately 
taken fromeachanimal.Two colonic pieces were used to investigate the CRF-induced NGF 
release, and two others for basal NGF release. Each segment was incubated for 15 min at 
37°C, in a Tyrode solution (composition, (mm): NaCl 136.9, KCl 2.68, CaCl2 1.8, MgCl2 
1.05,NaHCO3 1.19,NaH2PO4 0.42 and glucose 0.55). Then Tyrode solution containing CRF 
(10 µgml-1) or CRF-vehicle was added, andNGFreleased was determined for 1 h. NGF levels 
in the supernatant were measured by ELISA. Briefly, anti-NGF polyclonal Ab, which binds 
soluble NGF, was used at 100 µl well-1. The sample incubation was 6 h at room temperature. 
The captured NGF is bound by a second specific monoclonal antibody (mAb). After washing, 
the amount of specifically bound mAb is detected using an anti-rat IgG conjugated to HRP. 
After, incubation with a chromogenic substrate, the colour change is measured at 450 nmafter 
reaction was stopped. All these products were obtained from Promega (Lyon, France). NGF 
levels were expressed in pmol (ml supernatant)-1. 
 
Quantification of colonic mucosal CRF levels 
Under anaesthesia (i.p. administration of 0.6 mg kg-1 acepromazine (Vetoquinol, Lure, 
France) and 120 mg kg-1 ketamine (Rhone-M´erieux, Lyon, France)), rats were 
exsanguinated by beheading, and segments (4 cm) of distal colon were immediately taken 
from each animal. Mucosa was recovered and homogenized in PBS buffer supplemented with 
anti-protease cocktail (Roche, Meylan, France). Sample protein content was determined by a 
modified Lowry-based assay (Bio-Rad, Marnes-La-Coquette, France). CRF levels were 
determinedbyELISA(CosmoBio,Tokyo, Japan) according to the manufacturer’s instructions. 
CRF was quantified against a CRF standard curve and expressed as ng (mg protein)-1. 
 
Experimental protocol 
All experimentswere performedin 12-week-old-male rats. 
In a first set of experiments, four groups of eight contol and eight NMD rats were used. 
In a first group of rats, colonic preproCRF immuno-reactivity, mucosal colonic CRF level 
(distal segment) and corticosterone plasma level were determined. Rats (control and NMD) 
were both anaesthetized (10 AM) by i.p. administration of 0.6 mg kg-1 acepromazine 
(Vetoquinol, Lure, France) and 120 mg kg-1 ketamine (Rhone-M´erieux, Lyon, France), and 
both aortic blood and colonic samples were collected. Then rats were killed by cervical 
dislocation. 
In a second group of rats, two administrations of mifepristone, a corticoid receptor antagonist, 
was administered s.c. (4 mg kg-1 in 0.2 ml) 6 h and 1 h before measurement of GPP. 
In a third group of rats, two i.p. administrations of a-helical CRF(9-41) (a non-selective 
CRF1/CRF2-receptor (CRF-R1/CRF-R2) antagonist; 250 µg kg-1 in 0.2 ml)were similarly 
performed 6 h and 1 h before permeability measurement. 
A fourth group of rats received oral SSR-125543 (a selective CRF-R1 antagonist (Griebel et 
al. 2002); 10 mg kg-1 in 0.5 ml) 6 h and 1 h before assessing GPP. Another group of rats was 
used to evaluate the release of NGFfromcolonic strips in basal condition and under CRF 
stimulation. 
In a second set of experiments, six groups of eight contol rats were used. 
Group 1 received two i.p. administrations of CRF 1 h before and 6 h after starting the 
permeability measurement. 
Group 2 was treated by two i.p. administrations of doxantrazole (mast cell stabilizer; 5 mg kg-
1 in 0.2 ml; 6 h and 1 h before permeability measurement) and CRF (50 µg kg-1 in 0.2 ml; 1 h 
before and 6 h after starting the permeability measurement). 
Group 3 received two administrations of doxantrazole (5 mg kg-1 in 0.2 ml; 6 h and 1 h 
before permeability measurement). 
Group 4 was treated by two i.p. administrations of anti-NGF antibodies (15 µg kg-1 in 0.2 ml; 
6 h and 1 h before permeability measurement) and CRF (50 µg kg-1 in 0.2 ml; 1 h before and 
6 h after starting the permeability measurement). 
Group 5 received two i.p. administrations of BRX-537A (2 mg kg-1 in 0.2 ml; 1 h before and 
6 h after starting the permeability measurement). 
Group 6 was treated by two i.p. administrations  of anti-NGF antibodies (15 µg kg-1 in 0.2 
ml; 6 h and 1 h before permeability measurement) and BRX-537A (2 mg kg-1 in 0.2 ml; 1 h 
before and 6 h after starting the permeability measurement). 
All experimental protocols described in this study were approved by the local Institutional 
Animal Care and Use Committee. 
 
Drugs 
Doxantrazole was kindly supplied by Wellcome Research laboratories (Beckenham, UK), and 
was dissolved in 5% sodium bicarbonate. Mifepristone was a gift from Roussel-Uclaf (Paris, 
France), and was dissolved in olive oil.a-helicalCRF(9-41) waspurchased fromFisher 
(Illkirch, France), and was diluted in sterile saline solution. CRF was purchased from 
Calbiochem (VWR, Fontenay-sous-bois, France), and was diluted in saline solution. SSR-
125543 was kindly supplied by Sanofi-Aventis, and was dissolved in DMSO 5% and 
cremophor-EL 5%. Anti-NGF Ab was purchased from R&D Systems (R&D, Lille, France), 
and was diluted in sterile saline solution. BrX-537A (bromolasalocid ethanolate) was kindly 
supplied by Roche Laboratories (London, UK) and was dissolved in DMSO. 
 
Statistical analysis 
Results are expressed as means±s.e.m. Multiple groups were compared by Dunnett’s test after 
one-way ANOVA. Single comparisons were performed by non-parametric test (unpaired 
Student’s t test) for statistical analysis of CRFimmunoreactivity andCRFeffects on gut 
paracellular permeability. Differences were considered significant for P <0.05. 
 
Results 
 
Corticosterone and maternal deprivation 
In control rats, the corticosterone plasma concentration was 90±9 ngml-1. In NMD rats, this 
value was significantly increased to 138±17 ng ml-1 (P <0.05) (Fig. 1A). In NMD rats, GPP 
was significantly increased in comparison with control rats (4.1±0.2% versus 2.7±0.3%; P 
<0.05).However, mifepristone (4mg kg-1; s.c.) did not modify GPP in either control or NMD 
rats (P >0.05) (Fig. 2). 
 
PreproCRF, CRF and maternal deprivation 
An intense preproCRF labelling of enterocytes was observed in both control and NMD rats 
(Fig. 1B), while labelling of colonic bottom crypts and submucosa was weaker. In NMD rats, 
preproCRF immunoreactivity was significantly increased (P <0.05) in colonic mucosa, lamina 
propria layers and colonic bottom crypts, in comparison with control rats (Table 1 and Fig. 
1B). Surprisingly, as presented in Fig. 1C, no difference of CRF colonic mucosal levels was 
observed between control and NMD rats (3.9±0.4 ng (mg protein)-1 versus 4.2±0.2 ng (mg 
protein)-1; P >0.05). 
In NMD rats, an increased GPP was observed (3.9±0.3% versus 2.4±0.2%; P <0.05). both a-
helical CRF(9-41) and SSR-125543 suppressed the increase in GPP induced by maternal 
deprivation (P <0.05) (Fig. 3A and B). In control rats, GPP was not modified by either a-
helical CRF(9-41) or SS-125543 treatment (P >0.05). 
 
CRF and mast cells 
In control rats, CRF (50 µg kg-1) increased GPP (3.9±0.3% versus 2.1±0.2%; P<0.05). 
Doxantrazole treatment abolished the increase of GPP induced by CRF (2.6±0.4% versus 
3.9±0.3%;P <0.05), but hadnoeffect under basal conditions (1.9±0.2% versus 2.1±0.2%; P 
>0.05) (Fig. 4). 
 
 
 
Figure 1. Effect of NMD on corticosterone plasma levels, and both prepro CRF and CRF colonic mucosa expression in 
adult rats (12 weeks) 
A, corticosterone plasma level. B, preproCRF immunoreactivity (brown) in colonic sections of non-NMD (A1, A2) and NMD (B1, 
B2). A1, B1, bar = 50 µm, and A2, B2, bar = 10 µm. C, colonic CRF mucosa level. Control (open bars) and NMD rats (filled 
bars). Values are means ± S.E.M.; n = 8/group.∗P < 0.05 versus controls. 
 
 
NGF, CRF and mast cells 
In control rats, CRF (50 µg kg-1) increased GPP (3.9±0.3% versus 1.6±0.2%; P<0.05) (Fig. 
5). Anti-NGF Ab treatment reduced significantly the increase of GPP induced by CRF 
administration (2.8±0.3% versus 3.9±0.3%; P <0.05). However, the GPP observed after CRF 
plus anti-NGF Ab treatments, remained elevated comparedwith control rats (2.8±0.3% versus 
1.6±0.3%; P <0.05) (Fig. 5).Moreover, anti-NGF-neutralizing antibody treatment did not 
modify the GPP in adult control rat (data not shown; P >0.05). 
Similarly, mast cell stimulation by BRX-537A increased GPP (4.1±0.4% versus 1.8±0.2%; P 
<0.05) (Fig. 6). Anti-NGF Ab treatment reduced the increase of GPP induced by BRX-537A 
(3.1±0.4% versus 4.8±0.4%; P <0.05). However, the GPP still remained higher than that 
observed in control rat (3.1±0.4% versus 1.8±0.2%; P <0.05) (Fig. 6). 
In basal condition, the spontaneous release ofNGFfrom colonic strips of NMD and control 
rats was measured in the cleared supernatant obtained after 1 h of incubation (Fig. 7). The 
NGF amount released by colon sample from NMDrats was significantly higher (1073.2±48.4 
ng ml-1 versus 514.3±20.6 ng ml-1; P <0.01) than that of control rats. On colonic strips, CRF 
stimulated NGF release with a greater response in NMD than in control rats (1413.2±26.1 ng 
ml-1 versus 843.3±113.7 ng g-1; P <0.001) (Fig. 7). 
 
 
 
Figure 2. Effect of mifepristone on the increased GPP induced by NMD in adult rats 
Control (left) and NMD rats (right) were treated by vehicle (open bars) or mifepristone (filled bars). Values are means ± S.E.M.; n 
= 8/group. ∗P < 0.05 versus vehicle controls. 
 
Table 1. Effect of neonatal maternal deprivation on colonic preproCRF immunohistochemistry in adult rats 
 
Results were obtained from at least six different rats from control and NMD groups. Data (mean ± S.E.M.) are expressed as the 
total scoring, graded from 0 to 3 (0, no immunoreactivity; 1, weak immunoreactivity; 2, intermediate immunoreactivity; 3, strong 
immunoreactivity). ∗P < 0.05 from control (Student’s t test). 
 
Discussion 
This report demonstrates that NMD both increases corticosteronaemia and preproCRF 
immunoreactivity in the different colonic mucosa areas, but does not modify colonic mucosal 
levels of CRF in adult NMD rats. 
 
 
Figure 3. Involvement of CRF in the regulation of elevated GPP induced by NMD in adult rats 
A, effect of α-helical CRF(9-41) on the elevated GPP induced by NMD in adult rats. Control (left) and NMD rats (right) were 
treated by vehicle (open bars) or α-helical CRF(9-41) (filled bars). B, effect of SSR-125543A (CRF-R1 antagonist) on the 
increased GPP induced by NMD in adult rats. Control (left) and NMD-rats (right) were treated by vehicle (open bars) or SSR-
125543A (filled bars). Values are means ± S.E.M.; n = 8/group. ∗P < 0.05 versus vehicle controls. 
 
 
Figure 4. Role of mast cell degranulation on the increased GPP induced by CRF treatment in control rats 
Values are means ± S.E.M.; n = 8/group. ∗P < 0.05 versus Vehicle. 
 
Moreover, CRF but not corticosterone plays a major role in long-term alterations of the gut 
epithelial barrier triggered by NMD. This is supported by our data showing that the effects of 
NMD are suppressed by treatment of adult rats with a-helical CRF(9-41) or a CRF-R1 
receptor antagonist, but not by the glucocorticoid/progesterone receptor antagonist 
mifepristone.We demonstrate for the first time that CRF favours the release of NGF from 
colonic mast cells, which in turn is responsible for the increase of GPP. Indeed, doxantrazole 
treatment abolishes the increased GPP induced by CRF, and anti-NGF Ab reduces the CRF or 
BRX-537A-induced increase of GPP. This result is confirmed by the observed greater release 
of NGF in response to CRF in adult NMD rats. 
The neonatal period, roughly extending in rats from birth to day 14, is often referred to as a 
stress hyporesponsive period characterized by a diminished ACTH (adrenocorticotrophic 
hormone) and corticosterone response to most stressors (Rosenfeld et al. 1991). 
 
 
Figure 5. Involvement of NGF on the increased GPP induced by CRF treatment in control rats 
Values are means ± S.E.M.; n = 8/group. ∗P < 0.05 versus vehicle controls, †P < 0.05 versus CRF. 
 
Although NMD is known to affect the HPA axis function (Levine, 2001), the effects of NMD 
on plasma corticoid levels are inopposition. These differencesmay be explained by the rodent 
strain (Ellenbroek & Cools, 2000), sex (Wigger & Neumann, 1999; Barna et al. 2003), or the 
period where NMD (Van Oers et al. 1998) is applied (chronic or acute). In this study we have 
shown thatNMD increased plasma corticosterone in adult rats. Several hypothesesmay be 
considered. Firstly,NMDinducedNGF overexpression in colonic tissue of adult rats (Cirulli, 
2001; Barreau et al. 2004a). Since NGF promotes adrenal gland hypertrophy (Bigi et al. 1992; 
Alleva&Santucci, 2001) and glucocorticoid secretion (Otten et al. 1979, 1981), NGF 
overexpressionmay also stimulate corticosterone synthesis and accumulation in the blood. 
Secondly, NMD rats exhibited hyperresponsiveness to psychological stressors as compared to 
controls (Caldji et al. 2000; Ladd et al. 2000). This hyperresponsiveness results from a 
resistance to glucocorticoid-mediated negative feedback (Caldji et al. 2000; Ladd et al. 2000), 
which may participate in the elevated corticosteronemia. Thirdly, since NMD triggers 
bacterial translocation (Barreau et al. 2004b), leading to a downstream activation of the HPA 
axis (Ando et al. 2000), bacterial translocation induced by NMD may participate to increase 
corticosteronaemia in NMD rats. Recently, it was shown that acute stress increases plasma 
corticosterone, which in turn increases GPP (Meddings & Swain, 2000). However, in NMD 
rats, glucocorticoid receptor antagonist treatment failed to affect GPP. Consequently, a direct 
involvement of corticoids in the increased GPP can be excluded. 
 
 
 
Figure 6. NGF release from mast cells participated on the increased GPP induced by BRX-
537A in control rats Values are means ± S.E.M.; n = 8/group. *P < 0.05 versus vehicle, †P < 
0.05 versus BRX-537A 
By contrast with glucocorticoids, the effects ofNMDon CRF release and CRF receptor 
expression were extensively investigated in the central nervous system. Maternal deprivation 
induces a significant increase of CRF, CRF-R1 andCRF-R2mRNAexpression in the 
cortex,andadecrease of CRF-R1 and CRF-R2 mRNA expression in amygdala (Vazquez et al. 
2003). Although CRF secretion is mainly localized in the central nervous system, a colonic 
CRF production has been detected in the mucosal cells in the neighbourhood of the base of 
the colonic crypts (Kawahito et al. 1994), and an elevated colonic CRF expression has been 
observed in biopsies of patients with ulcerative colitis (Kawahito et al. 1995). In agreement 
with these previous studies, in the present study we have reported that both preproCRF and 
mature CRF are presentwithin the colonicmucosa.We have also shown for the first time that 
NMD increases preproCRF expression in several colonic mucosal areas, while it does not 
modify colonicmucosalCRFcontent in adult rats. This differential effect of NMD on colonic 
mucosa preproCRF and CRF levels may be explained by the fact that NMD may only alter 
preproCRF synthesis without modifying the rate of maturation of preproCRF into CRF. In 
addition, colonic content of CRF may result from both central and peripheral production of 
CRF. Consequently, this can explain the lack of relationship between preproCRF expression 
and tissue CRF concentration. 
 
 
 
Figure 7. Effect of NMD on spontaneous and CRF-induced NGF release from colonic mucosal mast cells in adult rats 
Control (left) and NMD rats (right) were treated by vehicle (open bars) or CRF (filled bars).Values are means ± S.E.M.; n = 
5/group. ∗P < 0.01 versus vehicle controls, †P < 0.001 versus CRF controls. 
 
CRF acts within the brain and pituitary to coordinate the overall endocrine and behavioural 
stress response. CRF is known to be involved in various stress-induced abnormalities in the 
gastrointestinal tract (Castagliuolo et al. 1996; Santos et al. 1999; Tache et al. 2001). A 
peripheral injection of CRF mimics stress-induced changes in colonic function regarding 
mucin release (Castagliuolo et al. 1996), ion secretion and permeability (Santos et al. 
1999).Moreover, physical and psychological stress in rats enhanced colonic epithelial 
permeability via peripheral CRF (Saunders et al. 2002). In this context, in this studywe have 
shown that CRF plays an important role in the elevated GPP induced by NMD through 
peripheral and/or central CRF-R1 receptor. Intraperitoneal a-helical CRF(9-41) or SSR-
125543 administration suppress the stress-induced increase of GPP. Furthermore, the 
suppressive effect of doxantrazole treatment on the increased GPP induced by CRF points out 
the involvement of mast cells. Because we have previously shown that colonic mucosa from 
adult NMD animals exhibit an elevated number of mast cells (Barreau et al. 2004b), we can 
also hypothesize that for a similarCRFcolonic content, more mast cells may be activated and, 
consequently, larger amounts of mediators participating in the elevated GPP induced by NMD 
can be released. 
As mast cells synthesize and release NGF (Leon et al. 1994), and NGF is known to be 
involved in the elevated GPP induced by NMD (Barreau et al. 2004a), we investigated CRF, 
NGF and mast cell interplay in the regulation of GPP. Firstly, we have shown that NGF 
release from mast cells under CRF and BRX-537A (mast cell activator) stimulation 
participates in the increased GPP in control rats. Indeed, anti-NGF Ab treatment significantly 
reduces the increase of GPP induced by CRF and BRX-537A. Secondly, in this study we have 
shown that CRF stimulation triggers a greater NGF release from colon biopsies of NMD rats 
than in control animals. Consequently, these data also support that NGF release from mast 
cells under CRF stimulation participates in the increased GPP in rats. However, the NGF 
receptor subtype (TrKa and P-75) (Vega et al. 2003) and cell type (nerve ending, epithelial 
cell, lymphocyte. . .) (Vega et al. 2003) involved in NGF-mediated increase of GPP remain 
unclear. Indeed, NGF released frommast cell may directly interfere with receptors located on 
epithelial cells or on nerve endings, stimulating the release of mediators or stimulating 
immune cells (lymphocytes) (Ferrier et al. 2003), which in turn increase GPP. Nevertheless, 
since anti-NGF Ab only partially lower the increase of GPP induced by CRF or BRX-537A, it 
can be suggested that other mediators such as rat mast cell protease II, cytokines (IL-4, IFNγ ) 
or neuromediators (substance P) are also involved. 
In summary, this study shows that NMD promotes long-term alterations of colonic 
preproCRF expression and corticosteronaemia level in adult NMD rats. CRF may interact 
with the CRF-R1 receptor to stimulate mast cell release of NGF, which in turn participates in 
the increased GPP in adult NMD rats. These results also provide evidence that adverse 
experiences in early life can induce neuroendocrine changes (HPA axis, NGF) associated with 
alterations of gut mucosa physiology in adult rats, and could have implications in the 
development of intestinal disorders such as IBS. 
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